NPPB and COVID-19: One case series reported decreased left ventricular ejection fraction and elevated cardiac markers such as pro-brain-type natriuretic peptide (proBNP) in critically ill pregnant women with COVID-19, with a mortality rate of 13% due to cardiac arrhythmia [15].